HAM/BIO0 (HAM/BIO0)

Hamburg Stock Exchange: HAM/BIO0 · EUR

€33.4

+0.20 (+0.6%)· Recorded snapshot

Market cap	1.3B
Revenue (ttm)	648.9M
Net income (ttm)	-70.7M
EPS (ttm)	-€1.79
Shares out	39.6M
Dividend	€0.04 (0.12%)
Volume	524

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 648.9M
Net income (ttm): -70.7M
EPS (ttm): -€1.79
Market cap: 1.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-14.2

P25 n/aP50 n/aP75 n/a

ROIC-4.8

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All HAM/BIO0 indicators

Market & fundamental data

Available fields

171

Groups with data

Currency

EUR

Showing 171 of 171 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Germany
Country code	DE
Earnings date	2026-11-02
Employees	2,698
Employees change	203
Employees growth	8.14%
Enterprise value	EUR 2.1B
Exchange	Hamburg Stock Exchange
Financial currency	EUR
Financial report date	2025-03-31
First seen	2026-07-12
Fiscal year end	December
Founded	1946
Industry	Biological Products, Except Diagnostic Substances
Is primary listing	Yes
ISIN number	DE000A41YE49
Last refreshed	2026-10-28
Market cap	EUR 1.3B
Next earnings date	2026-11-02
Price	EUR 33.40
Price currency	EUR
SIC code	2836
Stock price date	2026-10-27
Symbol	ham/BIO0
Website	https://www.biotest.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-5.35%
EV/Sales	3.18x
FCF / EV yield	-7.58%
FCF yield	-11.84%
P/B ratio	2.85x
P/S ratio	2.04x
Price / tangible book value	2.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-8.71%
EBITDA margin	-3.76%
Gross margin	10.71%
Operating margin	-8.71%
Pretax margin	-14.38%
Profit margin	-10.9%
Profit per employee	EUR -26,205
Revenue per employee	EUR 240,511
ROA	-2.38%
ROA (5Y)	0.61%
ROCE	-4.11%
ROE	-14.22%
ROE (5Y)	-0.75%
ROIC	-4.83%
ROIC (5Y)	0.59%
Tax / revenue	-3.48%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Gross profit growth	-80.11%
Gross profit growth (Q)	-84.44%
Gross profit growth 3Y	-5.29%
Gross profit growth 5Y	-13.07%
Revenue growth	-16.95%
Revenue growth (Q)	-42.29%
Revenue growth (QoQ)	-38.97%
Revenue growth 10Y	0.69%
Revenue growth 3Y	8.3%
Revenue growth 5Y	7.18%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -11.6M
Depreciation and amortization	EUR 32.1M
EBIT	EUR -56.5M
EBITDA	EUR -24.4M
EPS	EUR -1.79
FCF per share	EUR -3.95
Financing cash flow	EUR 135.4M
Free cash flow	EUR -156.5M
Gross profit	EUR 69.5M
Income taxes	EUR -22.6M
Investing cash flow	EUR -8.6M
Net borrowing	EUR 143.4M
Net cash flow	EUR -18M
Net income	EUR -70.7M
Operating income	EUR -56.5M
Revenue	EUR 648.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.84
Book value per share	EUR 11.71
Debt / equity	1.79
Goodwill	EUR 6M
Interest coverage	-1.64
Long-term assets	EUR 741M
Long-term liabilities	EUR 906.1M
Net cash (debt)	EUR -741.8M
Net cash / market cap	-56.13%
Net debt / equity	1.6
Piotroski F-Score	1
Property, plant and equipment	EUR 566.8M
Shareholders' equity	EUR 463.5M
Tangible book value	EUR 455.7M
Tangible book value per share	EUR 11.52
Total assets	EUR 1.5B
Total cash	EUR 89.8M
Total debt	EUR 831.6M
Total liabilities	EUR 1.1B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.44
Current assets	EUR 788.7M
Current liabilities	EUR 160.1M
Current ratio	5.63
Inventory turnover	1.15
Net working capital	EUR 654.2M
Quick ratio	2.05
Working capital	EUR 718.5M
Working capital turnover	1.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-26.88%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-07-24
Dividend payment years	2
Dividend per share	EUR 0.04
Dividend yield	0.12%
Ex-dividend date	2026-07-22
Last dividend	EUR 0.04
Shareholder yield	-26.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 32.82
1D price change	0.6%
1M price change	0.6%
1M total return	0.6%
1W price change	0.6%
1W total return	0.6%
1Y price change	13.61%
1Y return CAGR	13.75%
1Y total return	13.74%
20-day SMA	EUR 33.06
200-day SMA	EUR 32.56
3M price change	1.21%
3M total return	1.21%
50-day SMA	EUR 33.15
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 35.00
52-week high date	2026-05-15
52-week low	EUR 28.00
52-week low date	2026-07-31
6M price change	3.73%
6M total return	3.85%
All-time high	EUR 35.00
All-time high date	2026-05-14
All-time low	EUR 27.10
All-time low date	2025-01-16
Average true range (ATR)	EUR 0.47
Average volume	185.3
Beta (1Y)	0.19
Beta (2Y)	0.07
Change from 52-week high	-4.57%
Change from 52-week low	19.29%
Change from all-time high	-4.57%
Change from all-time low	23.25%
Change from open	10.6%
Day's gap	-9.04%
Dollar volume	EUR 17,502
High price	EUR 33.40
Low price	EUR 30.20
Monthly RSI	88.35
Open price	EUR 30.20
Position in 52-week range	100%
Previous close	EUR 33.20
Price vs 150-day SMA	1.77%
Price vs 20-day SMA	1.03%
Price vs 200-day SMA	2.58%
Price vs 50-day SMA	0.75%
Relative volume	2.83
RSI	54.54
Sharpe ratio	0.4
Sortino ratio	0.93
Volume	524
Weekly RSI	55.35
YTD price change	5.7%
YTD total return	5.82%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (QoQ)	0.58%
Shares change (YoY)	26.88%
Shares held by institutions	0.21%
Shares outstanding	39.6M

Deeper analysis on HAM/BIO0

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this HAM/BIO0 report

Is a complete HAM/BIO0 research report available?

No complete published report is available for ham/BIO0 (HAM/BIO0) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

HAM/BIO0 (HAM/BIO0)

Price

Financial snapshot

Fair-value bridge

Latest news · HAM/BIO0

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HAM/BIO0 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on HAM/BIO0

Frequently asked questions